Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy.
Transfusion
blood
hematology
home care
patient focused care
physician patient relations
Journal
Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
pubmed:
26
3
2021
medline:
21
5
2021
entrez:
25
3
2021
Statut:
ppublish
Résumé
One of the main obstacles of providing home-based palliative care to transfusion-dependent hematology patients is the lack of home transfusions services. While healthcare professionals are concerned with safety and cost of home transfusions, the attitude of the patients toward home transfusions are mostly unknown. To obtain quantitative data regarding the willingness and concerns of transfusion-dependent patients with hematological diseases toward the option of home transfusions. A cross sectional survey including a self-administered questionnaire in one of the three main spoken languages in Israel was administered to patients in 17 hospital hematology outpatient clinics between May 2019 and March 2020. About 52% of 385 patients that participated in the survey preferred home transfusions to hospital transfusions. Gender, age, education, or type of disease were not associated with preference for home transfusions, nor were hospital location or its size. The likelihood to prefer home transfusions was significantly higher among the Hebrew-speakers and those who had not experienced adverse effects previously. The most significant factor associated with preference of home transfusions was a perceived negative effect of hospital-based transfusion on quality of life. The main reason to reject home transfusions was fear of possible adverse effects and concerns over losing contact with the medical staff at the treating hospital. These data suggest that a significant portion of transfusion-dependent patients in Israel view home transfusions as a preferred treatment option and that its successful implementation requires maintaining ongoing contact with the treating hospital.
Sections du résumé
BACKGROUND
One of the main obstacles of providing home-based palliative care to transfusion-dependent hematology patients is the lack of home transfusions services. While healthcare professionals are concerned with safety and cost of home transfusions, the attitude of the patients toward home transfusions are mostly unknown.
AIM
To obtain quantitative data regarding the willingness and concerns of transfusion-dependent patients with hematological diseases toward the option of home transfusions.
DESIGN
A cross sectional survey including a self-administered questionnaire in one of the three main spoken languages in Israel was administered to patients in 17 hospital hematology outpatient clinics between May 2019 and March 2020.
RESULTS
About 52% of 385 patients that participated in the survey preferred home transfusions to hospital transfusions. Gender, age, education, or type of disease were not associated with preference for home transfusions, nor were hospital location or its size. The likelihood to prefer home transfusions was significantly higher among the Hebrew-speakers and those who had not experienced adverse effects previously. The most significant factor associated with preference of home transfusions was a perceived negative effect of hospital-based transfusion on quality of life. The main reason to reject home transfusions was fear of possible adverse effects and concerns over losing contact with the medical staff at the treating hospital.
CONCLUSION
These data suggest that a significant portion of transfusion-dependent patients in Israel view home transfusions as a preferred treatment option and that its successful implementation requires maintaining ongoing contact with the treating hospital.
Identifiants
pubmed: 33761783
doi: 10.1177/02692163211000634
pmc: PMC8114422
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
927-932Références
Leukemia. 2018 Aug;32(8):1697-1712
pubmed: 29880892
Transfus Med. 2005 Jun;15(3):219-22
pubmed: 15943706
Am J Health Behav. 2016 Sep;40(5):645-51
pubmed: 27561867
J Am Board Fam Med. 2014 Mar-Apr;27(2):169-71
pubmed: 24610178
Genet Med. 2017 Jun;19(6):609-619
pubmed: 27811859
Hematol Oncol Clin North Am. 2017 Aug;31(4):589-612
pubmed: 28673390
Transfus Med Rev. 2006 Jul;20(3):218-29
pubmed: 16787829
Community Pract. 2008 Jul;81(7):32-5
pubmed: 18655644
Lancet. 2017 Jun 24;389(10088):2531-2541
pubmed: 28495112
Gan To Kagaku Ryoho. 2019 May;46(Suppl 1):157-160
pubmed: 31189845
Eur J Health Econ. 2012 Jun;13(3):289-300
pubmed: 21660563
Lancet. 2017 Jun 24;389(10088):2503-2513
pubmed: 28495109
Int J Behav Med. 2020 Dec;27(6):647-659
pubmed: 32468510
Transfusion. 2018 Oct;58(10):2309-2319
pubmed: 30229938
J Clin Immunol. 2018 Nov;38(8):876-885
pubmed: 30421274
Lancet. 2017 Jun 24;389(10088):2542-2550
pubmed: 28495114